首页 >
法规速递
-
Certification Process for Designated Medical Gases-2026/2/11
2026-02-12查看详情 > -
Document: Electronic product information (ePI) roadmap-2026/3/20
2026-03-23查看详情 > -
Page: Use of macrolides, lincosamides and streptogramins (MLS) in animals in the European Union - Scientific guideline-2026/4/24
2026-04-27查看详情 > -
Document: Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia-2026/6/5
2026-06-08查看详情 > -
国家药监局综合司关于国家药监局批准药品电子注册证统一使用“国家药品监督管理局 药品注册专用章”电子印章有关事宜的通知 药监综药注函〔2022〕609号-2022/10/31
2022-11-14查看详情 > -
国家药监局药审中心关于发布《化药复方药物临床试验技术指导原则》的通告(2023年第15号)-2023/03/17
2023-03-17查看详情 > -
Draft Guidance: Biosimilarity and Interchangeability: Additional Draft Q&As on Biosimilar Development and the BPCI Act (Revision 1)-2023/9/15
2023-09-19查看详情 > -
CVM GFI #187B Heritable Intentional Genomic Alterations in Animals: The Approval Process-2025/1/7
2025-01-07查看详情 > -
Page: Medicines for human use under evaluation-2025/2/10
2025-02-11查看详情 > -
Document: Analysis and summaries of public consultation results: The European medicines agencies network strategy to 2028-2025/3/18
2025-03-19查看详情 >
